0,979  0,004  Analgesic
0,964  0,002  CYP2D6 substrate
0,964  0,003  Respiratory analeptic
0,941  0,002  Analgesic, opioid
0,940  0,001  Antitussive
0,939  0,002  Cocaine dependence treatment
0,925  0,001  UGT2B1 substrate
0,917  0,003  Psychostimulant
0,906  0,003  UDP-glucuronosyltransferase substrate
0,902  0,001  UGT1A3 substrate
0,897  0,003  Analeptic
0,885  0,005  CYP3A4 substrate
0,876  0,001  Toxic, respiratory center
0,867  0,002  Opioid agonist
0,866  0,002  UGT1A1 substrate
0,869  0,005  Teratogen
0,864  0,004  Dependence treatment
0,860  0,002  Opioid antagonist
0,859  0,005  Embryotoxic
0,855  0,004  Spasmolytic
0,844  0,001  Opioid mu receptor antagonist
0,839  0,003  Sedative
0,835  0,001  Opioid mu receptor agonist
0,834  0,003  Antipyretic
0,793  0,005  Sensitization
0,788  0,001  UGT2B7 substrate
0,789  0,002  Opioid delta receptor antagonist
0,790  0,003  Cardiodepressant
0,781  0,000  UGT2B9 substrate
0,777  0,003  Anesthetic general
0,773  0,001  Opioid kappa receptor antagonist
0,771  0,005  CYP2C19 substrate
0,769  0,003  Antialcoholic
0,768  0,003  Antidiarrheal
0,765  0,003  Anesthetic
0,770  0,009  CYP2C9 substrate
0,738  0,002  Opioid delta receptor agonist
0,736  0,005  5 Hydroxytryptamine release stimulant
0,675  0,000  Narcotic antagonist
0,661  0,001  Opioid kappa receptor agonist
0,656  0,003  Sigma receptor agonist
0,661  0,010  CYP1A2 substrate
0,645  0,004  Sigma receptor antagonist
0,619  0,004  Antipruritic
0,601  0,002  Constipation treatment
0,585  0,005  Muscle relaxant
0,561  0,004  Alpha 2 adrenoreceptor antagonist
0,552  0,004  Alpha 2a adrenoreceptor antagonist
0,548  0,004  Glutathione S-transferase substrate
0,554  0,015  Cardioprotectant
0,518  0,013  CYP2D6 inhibitor
0,496  0,015  Antineurogenic pain
0,519  0,041  Transcription factor NF kappa B inhibitor
0,478  0,004  Acetylcholine M1 receptor antagonist
0,487  0,022  UGT1A9 substrate
0,463  0,004  Antismoking
0,484  0,032  Stroke treatment
0,485  0,044  Antiparkinsonian
0,442  0,002  Toll-Like receptor 4 antagonist
0,431  0,004  Toll-Like receptor antagonist
0,430  0,006  Antidote
0,452  0,046  Immunosuppressant
0,400  0,008  Cholinergic antagonist
0,390  0,008  Acetylcholine antagonist
0,476  0,098  Antiinflammatory
0,394  0,040  NOS3 expression inhibitor
0,361  0,013  Pneumotoxic
0,359  0,014  Antipruritic, non-allergic
0,382  0,038  Antioxidant
0,387  0,048  Hepatic disorders treatment
0,371  0,033  Antihypoxic
0,320  0,006  Neuropathy treatment
0,343  0,033  Nitric oxide antagonist
0,336  0,042  Free radical scavenger
0,362  0,069  Vasodilator, peripheral
0,349  0,057  AR expression inhibitor
0,378  0,086  TNF expression inhibitor
0,329  0,041  Myocardial infarction treatment
0,322  0,035  5 Hydroxytryptamine uptake stimulant
0,302  0,029  Hepatoprotectant
0,304  0,044  Mutagenic
0,297  0,037  Antiparkinsonian, rigidity relieving
0,277  0,022  Cholinergic
0,265  0,012  Acetylcholine muscarinic antagonist
0,283  0,032  P-glycoprotein inhibitor
0,275  0,025  Skeletal muscle relaxant
0,260  0,010  Antiemetic
0,302  0,052  Hypoglycemic
0,319  0,070  Antidepressant
0,252  0,004  Prolactin inhibitor
0,251  0,007  Dopamine agonist
0,306  0,063  Hypoxia-inducible factor 1 alpha inhibitor
0,290  0,047  UGT1A6 substrate
0,236  0,004  Antihypermotility
0,244  0,014  Antihemorrhagic
0,361  0,133  Apoptosis agonist
0,270  0,043  Antihypotensive
0,302  0,077  Sodium/bile acid cotransporter inhibitor
0,235  0,010  Acetylcholine nicotinic antagonist
0,245  0,021  Alpha adrenoreceptor antagonist
0,269  0,051  Carcinogenic
0,219  0,005  Dopamine D2 agonist
0,242  0,029  UGT2B15 substrate
0,344  0,131  Alzheimer's disease treatment
0,239  0,030  Antiischemic, cerebral
0,293  0,090  Mood disorders treatment
0,264  0,062  Vasodilator
0,291  0,089  Prostate cancer treatment
0,204  0,005  Antiprotozoal activity enhancer
0,212  0,018  Expectorant
0,216  0,037  Prostate disorders treatment
0,197  0,019  Nav1.1 sodium channel blocker
0,213  0,038  Antiparkinsonian, tremor relieving
0,258  0,084  UGT2B4 substrate
0,275  0,104  Apoptosis antagonist
0,217  0,047  Lipocortins synthesis antagonist
0,187  0,017  Antineoplastic alkaloid
0,245  0,075  Antineoplastic (liver cancer)
0,261  0,092  Immunostimulant
0,201  0,033  Acetylcholinesterase inhibitor
0,266  0,099  Caspase 3 stimulant
0,231  0,065  Antihypertriglyceridemic
0,204  0,038  Interleukin 6 antagonist
0,199  0,037  UGT2B10 substrate
0,269  0,110  ICAM1 expression inhibitor
0,288  0,129  Antipruritic, allergic
0,276  0,124  Cognition disorders treatment
0,160  0,015  Acetylcholine M3 receptor agonist
0,157  0,012  Neuronal nicotinic receptor antagonist
0,229  0,083  NOS2 expression inhibitor
0,185  0,048  Uterine stimulant
0,194  0,060  UGT1A4 substrate
0,136  0,003  Prolactin release inhibitor
0,155  0,022  Breast cancer-resistant protein inhibitor
0,161  0,033  Antiadrenergic
0,191  0,063  LDLR expression enhancer
0,178  0,051  Lipid peroxidase inhibitor
0,138  0,013  Alpha 2d adrenoreceptor antagonist
0,268  0,143  Histamine release inhibitor
0,140  0,015  Tourette's syndrome treatment
0,176  0,052  Protein kinase stimulant
0,155  0,030  Alpha 2c adrenoreceptor antagonist
0,138  0,017  Dopamine D1 antagonist
0,220  0,102  Proliferative diseases treatment
0,214  0,097  Aldehyde oxidase inhibitor
0,243  0,127  Interleukin 2 agonist
0,124  0,011  Glycine receptor agonist
0,191  0,078  Abortion inducer
0,120  0,008  Dopamine D5 antagonist
0,210  0,098  Cardiovascular analeptic
0,168  0,057  NOS3 expression enhancer
0,157  0,046  DNA polymerase I inhibitor
0,302  0,192  Caspase 9 stimulant
0,115  0,005  Nociceptin (N/OFQ) receptor antagonist
0,219  0,113  Chemoprotective
0,148  0,049  Cyclooxygenase 3 inhibitor
0,158  0,061  Genotoxic
0,203  0,107  Vascular (periferal) disease treatment
0,186  0,091  Neurotrophic factor enhancer
0,257  0,166  CYP2C19 inhibitor
0,166  0,075  Prostatic (benign) hyperplasia treatment
0,125  0,037  Creatine kinase inhibitor
0,140  0,052  Adenylate cyclase inhibitor
0,223  0,140  CTGF expression inhibitor
0,241  0,158  Calcium channel activator
0,158  0,079  Chemopreventive
0,172  0,092  Antimigraine
0,122  0,043  Adrenaline antagonist
0,142  0,065  Ca2+-transporting ATPase inhibitor
0,124  0,049  Estrogen antagonist
0,103  0,030  Glycine receptor antagonist
0,138  0,065  Nav1.2 sodium channel blocker
0,110  0,038  SULT1E1 substrate
0,129  0,056  Contraceptive female
0,118  0,047  Sulfotransferase substrate
0,088  0,020  Uterine relaxant
0,071  0,003  NMDA receptor phencyclidine site antagonist
0,103  0,036  Tocolytic
0,111  0,045  Estrogen receptor beta antagonist
0,110  0,045  UGT2B11 substrate
0,200  0,136  Tyrosine 3 hydroxylase inhibitor
0,173  0,109  VEGF expression inhibitor
0,211  0,148  FMO3 substrate
0,141  0,080  Antimutagenic
0,104  0,044  Acetylcholine agonist
0,082  0,023  SULT2A1 substrate
0,192  0,133  Huntington's disease treatment
0,118  0,060  Alpha 2b adrenoreceptor antagonist
0,100  0,045  Restless leg syndrome treatment
0,072  0,019  Postcoital contraceptive
0,100  0,047  Androgen antagonist
0,093  0,041  Dopamine antagonist
0,063  0,011  Nicotinic receptor beta4 subunit antagonist
0,078  0,026  Dopamine uptake inhibitor
0,069  0,020  Acetylcholine M2 receptor agonist
0,086  0,037  Dopamine D2 antagonist
0,053  0,004  Dopamine D1 agonist
0,142  0,094  Growth hormone agonist
0,049  0,004  Vesicular acetylcholine transporter inhibitor
0,118  0,072  M18 aspartyl aminopeptidase inhibitor
0,132  0,087  SULT1A3 substrate
0,093  0,049  Antineoplastic antibiotic
0,148  0,107  Cytotoxic
0,065  0,024  Nicotinic receptor alpha7 subunit antagonist
0,107  0,068  Electron transport complex I inhibitor
0,112  0,075  Autism spectrum disorders treatment
0,222  0,185  Antiobesity
0,098  0,063  Dementia treatment
0,124  0,090  Hair growth stimulant
0,096  0,062  Vascular dementia treatment
0,165  0,132  Antihypercholesterolemic
0,186  0,155  Flavin-containing monooxygenase substrate
0,056  0,025  Nicotinic receptor alpha4 subunit antagonist
0,113  0,084  Antiviral (Influenza B)
0,036  0,008  Nociceptin (N/OFQ) receptor agonist
0,055  0,028  Dopamine transporter inhibitor
0,078  0,052  Na+ K+ transporting ATPase inhibitor
0,133  0,108  Melanin inhibitor
0,064  0,039  NMDA 2C receptor antagonist
0,113  0,090  Contraceptive
0,074  0,055  SULT1A2 substrate
0,114  0,097  Antineoplastic (squamous cell carcinoma)
0,058  0,041  Lipocortins synthesis agonist
0,140  0,126  Antiviral (Influenza)
0,059  0,046  Adrenaline uptake inhibitor
0,049  0,036  Estrogen agonist
0,073  0,060  Antitreponemal
0,079  0,067  CC chemokine 5 receptor agonist
0,090  0,079  Anabolic
0,193  0,182  CYP3A4 inhibitor
0,158  0,148  Acute neurologic disorders treatment
0,042  0,032  Nicotinic receptor alpha3 subunit antagonist
0,041  0,032  Acetylcholine M1 receptor agonist
0,118  0,110  Antiviral (Influenza A)
0,044  0,036  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,069  0,061  Cushing's syndrome treatment
0,030  0,022  Acetylcholine M4 receptor agonist
0,050  0,044  Postmenopausal disorders treatment
0,028  0,022  RNA-directed RNA polymerase stimulant
0,029  0,024  Estrogen receptor beta agonist
0,123  0,118  Adenylate cyclase stimulant
0,049  0,045  Acetylcholine muscarinic agonist
0,063  0,059  NMDA 2 receptor antagonist
0,042  0,039  Antibiotic Glycopeptide-like
0,032  0,030  Tubulin agonist
0,035  0,034  Glucose-6-phosphate dehydrogenase inhibitor

